黄金城集团

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Mithramycin suppresses DNA damage repair via targeting androgen receptor in prostate cancer

Cancer Lett. 2021-05-01; 
Shan Wang, Collin Gilbreath, Rahul K Kollipara, Rajni Sonavane, Xiaofang Huo, Paul Yenerall, Amit Das, Shihong Ma, Ganesh V Raj, Ralf Kittler
Products/Services Used Details Operation
Catalog Antibody … Signaling, 5247), ERG Antibody (Abcam, ab92513), PSA Antibody (Abcam, ab137330), XRCC4 Antibody (Santa cruz, sc-271087), RFC3 Antibody (Santa cruz, sc-390293), FANCC antibody (Epigentek, A62566), THE V5 Tag Antibody (Genscript, A01724); Immunohistochemistry … Get A Quote

摘要

The dependency of prostate cancer (PCa) growth on androgen receptor (AR) signaling has been harnessed to develop first-line therapies for high-risk localized and metastatic PCa treatment. However, the occurrence of aberrant expression, mutated or splice variants of AR confers resistance to androgen ablation therapy (ADT), radiotherapy or chemotherapy in AR-positive PCa. Therapeutic strategies that effectively inhibit the expression and/or transcriptional activity of full-length AR, mutated AR and AR splice variants have remained elusive. In this study, we report that mithramycin (MTM), an antineoplastic antibiotic, suppresses cell proliferation and exhibits dual inhibitory effects on expression and transcriptio... More

关键词

Androgen receptor, Bleomycin, DNA damage Repair, Ionizing radiation, Mithramycin